Pacira BioSciencesvsThermo Fisher Scientific

PCRX and TMO stock compared: price, dividend, valuation and results, from SEC filings.

PCRX

Pacira BioSciences, Inc.

$36.48

Value $1.5B

+0.00%
PCRX's page

TMO

Thermo Fisher Scientific Inc

$686.79

Value $255B

-0.66%
TMO's page

Pacira BioSciences (PCRX) has a market value of $1.5B and Thermo Fisher Scientific (TMO) $255B. Over the last year, with dividends, PCRX moved +53.4% and TMO +19.1%. The P/E is 39.2 for PCRX and 36.1 for TMO. Dividend yield: PCRX none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    PCRX$1.5B

    TMO$255B

    TMO is 173 times PCRX

  • Revenue, 12 months

    PCRX$743M

    TMO$47.4B

    TMO is 64 times PCRX

  • Net income, 12 months

    PCRX$38M

    TMO$7.1B

    TMO is 187 times PCRX

  • Operating margin

    PCRX4.8%

    TMO17.9%

    13.1 points apart

  • ROIC

    PCRX2.4%

    TMO8.2%

    5.8 points apart

  • P/E

    PCRX39.2

    TMO36.1

    PCRX is 1.1 times TMO

  • Dividend yield

    PCRX0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    PCRX-36.0%

    TMO+8.6%

    44.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

PCRX-36.0%

TMO+8.6%

5010015020222023202420252026
Returns by period
PeriodPCRXWith dividendsTMOWith dividends
1 year since November 14, 2025+53.4%Price +53.4%+19.1%Price +18.7%
3 years since November 17, 2023+30.8%+9.4% a yearPrice +30.8%+48.7%+14.1% a yearPrice +47.2%
5 years since November 16, 2021-36.0%-8.5% a yearPrice -36.0%+8.6%+1.7% a yearPrice +7.1%
10 years since November 18, 2016+1.3%+0.1% a yearPrice +1.3%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

PCRXPacira BioSciencesTMOThermo Fisher Scientific

Valuation

PCRXTMO
Valuation
Price$36.48$686.79
Market value$1.5B$255B
Enterprise value (EV)$1.5B$290B
P/E39.236.1
P/E, 5-year median–32.7
P/B2.14.7
EV/EBIT41.234.3
Free cash flow yield11.4%3.0%

Results and growth

PCRXTMO
Results and growth
Revenue, 12 months$743M$47.4B
Net income, 12 months$38M$7.1B
Free cash flow, 12 months$169M$7.6B
Earnings per share, 12 months$0.93$18.96
Revenue growth, year on year3.6%3.9%
Revenue growth a year, past+11.1%over 5 years+6.7%over 5 years
EPS growth a year, past-45.5%over 5 years+2.1%over 5 years

Margins and returns on capital

PCRXTMO
Margins and returns on capital
Gross margin78.7%–
Operating margin4.8%17.9%
Net margin5.1%14.9%
ROIC2.4%8.2%
ROE5.5%13.4%

Balance sheet

PCRXTMO
Balance sheet
Cash$296M$6.1B
Total debt$340M$41.4B
Net debt / EBITDA-0.03.7
Interest cover2.5×5.5×

Dividends and buybacks

PCRXTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield10.0%1.2%
Shareholder yield10.0%1.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: PCRX or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Pacira BioSciences or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($255B) is about 172.7 times Pacira BioSciences ($1.5B), at today's prices.

How did PCRX and TMO stock do over the last 10 years?

Since November 18, 2016, PCRX's price moved +1.3% and TMO's +371.0%. With dividends: PCRX +1.3% (+0.1% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, PCRX or TMO?

The dividend yield at today's price is none for Pacira BioSciences and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of PCRX and TMO?

At today's price, the P/E is 39.2 for PCRX and 36.1 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Pacira BioSciences or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 5.1% for Pacira BioSciences and 14.9% for Thermo Fisher Scientific, and the operating margin 4.8% and 17.9%. Revenue was $743M and $47.4B.

Which is the better investment, Pacira BioSciences or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.